IMPACT Therapeutics
PrivateLast Round
IPO Announced
Mar 27, 2026
Total Funding Raised
$169.7M
Company Overview
IMPACT Therapeutics is a biotechnology company that develops novel therapeutics to treat cancer and other life-threatening diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Revenue Share
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
IMPACT Therapeutics Comps
Public and private peers based on sector, stage, and business model.
IMPACT Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| IPO Announced | Mar 27, 2026 | ||||
| Series D Extension | Nov 15, 2024 | ||||
| Series D Extension | Apr 22, 2024 | ||||
| Series D | Mar 14, 2022 | ||||
| Series C Extension | Nov 30, 2020 | ||||
Series C | Aug 3, 2018 |
IMPACT Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Dingxin Capital | Series D |
| Decheng Capital | Series C |
| Xiamen C&D Emerging Industry Equity Investment | Series D Extension |
| Exome Asset Management | Series D |
| Lilly Asia Ventures | Series D, Series D Extension, Series C Extension, Series C |
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 27, 2026
Completed an IPO round of funding.
IMPACT Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about IMPACT Therapeutics's valuation, stock price, and market status.
